Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial
Cancer Cell · 2023-10 · 41 (10) · 1705-1716.e5
DOI: 10.1016/j.ccell.2023.09.004 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cancer Cell, 2023-10. Verfasst von Mu-Chen Zhang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin H…. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Antineoplastic Combined Chemotherapy Protocols, Immunotherapy. Die Arbeit wurde bisher 135-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Education Commission, Changjiang Scholar Program, Ministry of Education, School of Medicine, Shanghai Jiao Tong University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine…
- Department of Pathology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Nuclear Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Radiology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Research and Development, Shanghai Righton Biotechnology Co. Ltd, Shanghai, China.
Förderung
- Shanghai Municipal Education Commission
- Changjiang Scholar Program, Ministry of Education
- School of Medicine, Shanghai Jiao Tong University
- Samuel Waxman Cancer Research Foundation
- Shanghai Municipal Hospital Development Center
- Center for High Performance Computing, Shanghai Jiao Tong University
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Zhang, M. C., Tian, S., Fu, D., Wang, L., Cheng, S., Yi, H. M., Jiang, X. F., Song, Q., Zhao, Y., He, Y., Li, J. F., Mu, R. J., Fang, H., Yu, H., Xiong, H., Li, B., Chen, S. J., Xu, P. P., & Zhao, W. L. (2023). Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial. Cancer Cell, 41(10), 1705-1716.e5. https://doi.org/10.1016/j.ccell.2023.09.004
Vancouver
Zhang MC, Tian S, Fu D, Wang L, Cheng S, Yi HM, et al. Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial. Cancer Cell. 2023;41(10):1705-1716.e5. doi:10.1016/j.ccell.2023.09.004
BibTeX
@article{Zhang2023,
author = {Zhang, Mu-Chen and Tian, Shuang and Fu, Di and Wang, Li and Cheng, Shu and Yi, Hong-Mei and Jiang, Xu-Feng and Song, Qi and Zhao, Yan and He, Yang and Li, Jian-Feng and Mu, Rong-Ji and Fang, Hai and Yu, Hao and Xiong, Hui and Li, Biao and Chen, Sai-Juan and Xu, Peng-Peng and Zhao, Wei-Li},
title = {Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial},
journal = {Cancer Cell},
year = {2023},
volume = {41},
number = {10},
pages = {1705--1716.e5},
doi = {10.1016/j.ccell.2023.09.004}
}
EUVIMED